Connect with us

Cannabis News

Coca Prohibition Is More Harmful Than The Plant Itself, World Health Organization Review Concludes

Published

5 months ago

on

“Research records, however, documents strongly documented public health damage related to position strategies in all scales”.

Mattha Busby, filter

The consumption of coca-leaf during the Andes does not have a significant risk, but the official CCO control strategies are linked according to a review of “Public Health Damage”.

Filter It was a previous copy of the report distribute Expert Commission on Drug Addiction (ECDD).

Coca, a stimulating and medicinal component of the cocaine component, banned by UN 1964 His researchers claimed Chewing the coca leaf is “definitively harmful” and “cause of racial degeneration of many population groups.” A who is also the paper as well describe Using a rich calcium plant “as a social disease”.

Despite the production of location leaves, during decades, Peru, Bolivia and Ecuador, during the drug war, indigenous communities remain in deep spiritual values ​​- in the height of all time in Colombia.

“Reviewed research for this report does not reveal evidence caused by the damage to public health related to coca leaves” to states ECDD’s extensive scientific review of commissioned. “Research records, however, documents strongly documented public health damage related to position strategies in all scales”.

The review is currently in draft mode and is subject to copying. It was commissioned among the growing international citation Koke, to finish the prohibition of Coca Filter previously reported.

In October, an international group of independent experts contracted by ECDD, and should be taken into account the most limited situation to change in the Coca’s current program. The meaning is that researchers understand the sources of leaves that understand the impossible.

One of the recommendations would be presented in December to the Narkotic Drug Commission, with a rotating member of 53 National Member States. In March 2026, the CND will vote for any recommendation. Coca may change or disable, which would have great ramifications, finish his use of criminalization and potentially providing an important economic economy in Latin American producers.

“We haven’t been a recommendation for the Commission, but it will be difficult to recommend how they could recommend KOKA Calendar,” Steve Rolls, Transform Drug Policy Foundation, charity campaign, drug legal regulation Filter.

“It’s quite likely to recommend (ECDD) really desecute, that is, they expect a lot of people in Colombia, Bolivia and civil society,” he continued. “Leaving the Coca in any schedule does not implicitly criminalizes millions of people who use it traditionally.”

However, those who make a scholarship recommendation, Rolles expects the CND currently The United Kingdom, Saudi Arabia and China counts among members, to vote. “The banners would be around forbiders and any desecrants would be forbidden because they were so paranoids around the cocaine,” he said.

In February, President Colombia gave the President Gustavo Petro Legalization of cocaine, described “worse than whiskey”. The external government of Bolivia’s left and indigenous government is called “Coca leaf colonization”, “but it will not be very difficult that the right government will put reform.

Whosely-based pesticides based on the rounded papers showed exposure, with a safe carcinogene, the number of medical consultations in the coke crop crop is “increased by the number of medical communities and breathing.”

He added that another study was eligible to increase coca farmers with increasing production of production, “increasing the exposure to the subsequent coca-plots” increasing exposure to chemicals. “

In the 1990s Coca farmers destroyed their crops and even when they were arrested and prosecuted for traditional uses. “Chronic exposure to agro-chemical products increases health risks related to neurological damage, bodies failure and reproductive health problems,” the papers said. “Pesticides and other farmers worked in the planned crop can cause security profiles and health profiles and health risks related to the use of the workshop.”

Indigenous spilled areas also complained “Flu symptoms, including nausea, dizziness, intervals, diarrhea, depending on the 2001 Report of the 2001 Institute”, according to the 2001 Republic of the Institute, Progressive thought.

“At least it seems that the discussion will encourage science and evidence,” Ricardo Sobern, Devida, the former president of the official drug control committee, said, said Filter. “Latin American states, as well as 53 members of CND, I must understand that the desktop will strengthen the gang fighting.”

The director of the Martin Jelsma, the Transnational Institute, said the review report “clearly” establishes that there is no harm or dependency of public health related to Coca leaf. “In terms of use of medicines, the evidence is still preliminary, but the potential is” great interest “to establish efficiency and safety for future development in human medicine”, ” Filter. “These basic consequences remove the original justification at the I.

The only reason to keep the coca leaf will remain in cocaine cocaine, “and the report indicated that the cocaine can be created from the Coca leaf” solvent extraction “than the process of” conversion “that assumes the chemical transformation of the molecule.”

The report refers to Koka’s cultural meaning, as well as the use of herbal medicine, but the violation of indigenous and human rights rights “intentionally avoided the impact of current controls,” he said.

The revision does not have the result of the healthcare consequences of the enforcement strategy of eradication of coca and eradicate traffic supply, Many experts say fuel violence.

Composing issues created as a result of prohibition by Coca, conservation campaigns said to eradicate the efforts that often comply with the growers to be further from the inspections of law enforcement.

The report is to use food in Coca, drinks such as energy tonic and beer, they are also increasing cosmetics that claim anti-aging properties and fabrics.

Although the report is noticed by public health damage associated with the leaf, the report has said “Undercoming literature on botanical, historical and cultural leaves, which evaluate their clinical effects are properly designed.” However, he said, “There is no evidence … a serious coca-leaf of humans.”

This article was originally published FilterUse of drug use, drug policy and human rights to reduce the damage to the online magazine through a lens. Continue filter Blues, X or Ocuookand Sign up for his newsletter.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Related Topics:
Continue Reading

Cannabis News

Cannabis products recalled due to “unreliable” tests

Published

13 hours ago

on

March 3, 2026

By











New York State’s Office of Cannabis Management (OCM) has recalled several cannabis products after finding that reported results from a testing laboratory were “unreliable.”

OCM says it has found a total of 54 product lots that tested false positive for Aspergillus, the mold that causes disease. According to OCM, another batch of product had incorrect results for the heavy metal cadmium.

“When test results are inaccurate or unclear, product safety and, in turn, the safety of New York State consumers cannot be guaranteed,” said OCM Executive Deputy Director of Licensing, Enforcement and Laboratories Stephen Geskey. “It’s not a risk OCM is willing to take.”

This information comes from an audit of inspections and records conducted by Keystone State Testing New York between December 2025 and January 2026. According to OCM, there have been no reports of the effects of consuming any of the products.

Read more at News 10










Continue Reading

Cannabis News

Virginia House And Senate Lawmakers Advance Marijuana Sales Legalization Bills Toward Governor’s Desk

Published

14 hours ago

on

March 3, 2026

By

The march to legalize the sale of recreational marijuana in Virginia continues, with the full House of Representatives and a Senate committee advancing a pair of bills to create a regulated adult cannabis market in the commonwealth.

The House on Tuesday approved the second reading of the cannabis sale bill passed by the Senate, giving it the chance to pass it definitively in the chamber. Earlier, a House measure moved through the Senate Finance and Appropriations Committee on a 10-5 vote, sending the measure back to the floor for consideration.

Both chambers’ marijuana-sale proposals aim to give adults a legal way to buy cannabis, legalizing both state possession and home cultivation in 2021, though there are key differences between them.

Bicameral measures—HB 642 and SB 542—Recently changed to allow micro business licensees to cultivate, process or conduct retail sales at two locations instead of one, as long as they are within 10 miles of each other and operate under common ownership and control.

Lawmakers also revised the legislation to clarify that current medical cannabis businesses would only be able to grow cannabis indoors, including in secure greenhouses with a total hood of 70,000 square feet. The amendments also would not allow additional marijuana licenses with “dual-use privileges” beyond medical licenses.

Finally, the measure’s conversion fee structure was revised to pay current medical marijuana companies the privilege of dividing the adult-use market into three parts.

There are some key differences between the House bills that still need to be ironed out — related to the start date of legal sales and cannabis tax rates — before a final product can be delivered to the governor’s desk.

Here are the key details of Virginia’s marijuana sales legalization legislation, SB 542 and HB 642:

  • Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products, as determined by regulators.
  • The House bill sets a statewide sales date of Nov. 1, 2026, while the Senate measure would allow it to begin on Jan. 1, 2027.
  • The Senate bill would impose a 12.875 percent excise tax on cannabis products, in addition to a 1.125 percent state sales tax and a mandatory 3 percent local tax. The House measure would apply a 6 percent excise tax, as well as a 5.3 percent retail sales and use tax, allowing municipalities to impose a 3.5 percent local tax.
  • Under the House bill, the Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, while the Senate legislation calls for a new combined Alcoholic Beverage and Cannabis Control Authority.
  • The House bill calls for the proceeds to be allocated to a new Cannabis Equity Reinvestment Fund (60 percent), early childhood education (10 percent), the Department of Behavioral and Developmental Health Services (25 percent) and public health initiatives (5 percent). The Senate proposal, on the other hand, would put 30 percent into the capital reinvestment fund, 40 percent for early childhood education, 25 percent for the department of behavioral and developmental health services and 5 percent for public health initiatives.
  • Local governments could not allow marijuana companies to operate in their area.
  • Delivery services would be allowed.
  • Serving sizes would be limited to 10 milligrams of THC, with no more than 100 mg of THC per package.
  • Existing medical cannabis operators could enter the adult-use market if they pay a license conversion fee set at $15 million in the Senate bill and $10 million in the House measure.
  • Cannabis businesses should implement peaceful labor agreements with their employees.
  • A legislative committee would direct the addition of local consumer licenses and micro-enterprise cannabis event permits that would allow licensees to hold sales at farmers markets or pop-up locations. The Virginia Alcoholic Beverage Control Authority would also investigate the possibility of involvement in marijuana regulation and enforcement.

Both the Virginia House and Senate Last month, he took action on multiple marijuana bills during a major deadline—accept proposals to legalize the sale of cannabis, provide a way to punish previous marijuana convictions and allow access to medical cannabis for seriously ill patients in hospitals.

As for the Senate marijuana sales bill, members recently clashed in committee over amendments to the body version that would add new penalties for illegal cannabis activity.

The amendments in the Judiciary Committee’s case included penalties for consumers who purchase from unlicensed sources, recriminalizing possession and sale of cannabis by those under 21, making it a Class 1 felony for a first offense and a felony punishable by a mandatory prison sentence for a second offense. As revised, the bill would also increase the penalty for unlicensed cultivation to a felony with up to five years in prison and make it a felony to transport cannabis with the intent to distribute it across state lines.

But the Finance and Appropriations Committee backed down the amendments last month, sending a letter to senators under pressure from a coalition of advocacy groups. saying that they undermined the “intent” of the legislation and “the will of the people” by adding criminal penalties to certain cannabis-related activities.

In general, both chambers’ commercial sales bills have largely aligned with recommendations released by the legislature in December. Joint Committee to Oversee the Transition to the Commonwealth Retail Cannabis Market.

Meanwhile, some members of the GOP have aligned ideologically with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus. in favor of creating a regulated market for adults to buy cannabis.

Since legalizing cannabis ownership and home cultivation in 2021, Virginia lawmakers have been working to establish a commercial marijuana market– Only for those efforts to stall under former Gov. Glenn Youngkin (R), who twice vetoed measures sent to his desk by the Legislature.

Governor Abigail Spanberger (D), for her part, supports legalizing the sale of marijuana to adults..

Meanwhile, members of the Virginia House and Senate advanced a pair of bills Monday, with amendments that provide a pathway to resentencing for people with prior marijuana convictions.

Members of the Senate and House Judiciary Committees approved alternate versions of the opposite chamber’s reform bill on Monday, setting the stage for bicameral negotiations as the measures move through the legislative process.

Legislation introduced in both chambers would create a process to consider changing the sentences under which people incarcerated or on community custody for certain felonies involving the possession, manufacture, sale or distribution of marijuana could receive an automatic trial.

Separately last month, the Virginia House patients passed a bill to allow the use of medical marijuana in hospitals. It would require health care facilities to implement policies “to address the situation in which an eligible patient is authorized to use medical cannabis.”

The Senate passed various pieces of legislation use of medical cannabis in healthcare facilities last month

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Meanwhile, the Virginia House passed the bill earlier this month Protecting the rights of parents who use marijuana by complying with state laws.

Del. According to the proposal by Nadarius Clark (D), a parent or guardian’s own use of cannabis “shall not serve as a basis for a finding of abuse or neglect of a child unless other facts establish that its possession or consumption causes or produces physical or mental injury to the child.”

“A person’s legal possession or consumption of substances permitted (under state marijuana law) shall not serve as a basis for limiting custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” reads the text of HB 942.

Separately, the Virginia Department of Labor and Industry has published a new defining workplace protections for cannabis users.

Photo by Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Swiss company launches nationwide price comparison tool for cannabis

Published

2 days ago

on

March 2, 2026

By











Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.

Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.

Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.

The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.

“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”

The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.

For more information:
Evidena Care AG
Email: (email protected)
https://evidena.care/










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media